Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series. Eur J Intern Med. 2021 11; 93:87-94.